Abstract
BackgroundElevation of C-reactive protein (CRP) is a marker of adverse outcomes in acute coronary syndromes (ACS). Its role has not been evaluated in patients with stable coronary artery disease (CAD)...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
